You are here

Home » Content

Otozomal Dominant Polikistik Böbrek Hastalığında Renal Replasman Tedavileri

Renal Replacement Therapies in Autosomal Dominant Polycystic Kidney Disease

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2007
Author NameUniversity of AuthorFaculty of Author
Bookmark/Search this post with
Abstract (Original Language): 
Otozomal dominant polikistik böbrek hastalığına CODPBH) bağlı son dönem böbrek yetmezliği (SDBY) genellikle 601ı yaşlarda gelişmektedir. ÖDPBH olan hastaların çoğunda uzun yıllar içerisinde glomerüler filtrasyon hızımla ilerleyici bir azalma gözlenmektedir. Hastaların yaklaşık yarısı SDBY nedeniyle diyaliz tedavisine İhtiyaç göstermektedir (1). j Diğer nedenlere bağlı böbrek vctmezlikli hastalara göre daha ivi diyaliz sonuçlan olduğu bildirilmektedir (2). Son dönem böbrek yetersizliği gelişimi 40 yaşın j alımda oldukça nadir olup, hastalığın progresyo- I nunda değişik faktörler rol oynamaktadır (3,4). j Genç bir hastada polikistik böbrek tanısı konduğun- ; da daha erken SDBY gelişeceği bildirilmektedir. Otuz yaşından önce tanı konulması durumunda renal sun inin 30 yaşın üzerinde tanı konulanlara göre. 10 yıl daha kısa olduğu saptanmıştır (5). Erkek hastalarda kadın hastalara göre daha hızlı bir seyir gözlenmekte ve diyalize başlama ?-6 yıl daha erken j oluşmakladır (1,6-9).
FULL TEXT (PDF): 
PDF icon arastrmx_172977_16_pp_40-45.pdf
  • 1
40-45
  • Turkish

REFERENCES

References: 

1. Brenner Rectors. The Kidney, 6th eti. Wll Saunders Company, Philadelphia 2000, pp 1699-710.
2. Perrone RD, Rulhazer R.,Terrin NC. Survival after end-slage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality. Am J Kidney Dis 2001 Oct;38(4):777-84,
3. Parfrey, PS, Bear, JC, Morgan. J, et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323:1085.
4. Gabow, PA, Johnson, AM, Kaehny, WD, et al. Factors affecting the prognosis of renal disease in autosomal-dominant polycystic kidney disease. Kidney [fit 1992; 41:1311¬5. Johnson, AM, Gabow, PA. Identification of patients wiili autosomal dominant polycystic kidney disease al highest risk for end-stage renal disease. J Am Soc Nephrol 1997; 8:1560.
6. Davison AM, Cameron JS, Grunfeld IP, Kerr DS, Rİlz E and Winearls C. Oxford Textbook of Clinical Nephrology, 2nd ed.
44
Türk
Nefroloj
i Diyaliz ve Transplantasyon Dergisi /Official Journal of the Turkish Society of Nephrology
Otozomal Dominant Polikistik Böbrek Hastalığında Renal Replasman Tedavileri %
l'Diversity Press 1998. pp 2376-2409¬7. Ishikava I. Maeda K. Nakai S. Kavaguchi Y. Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am I Kidney Dis.2000 Jun;35(6); 1072-5. S. Kalre S. Leivestad T, Fauchald P. Active uremia therapy in autosomal dominant polycstic disease. Tidssler Nor Laegeforen. 2000 March 30;120(9):1015-9.
9. Choukroun G, Hakura Y, Alhou/e G, ChristopheJL, Man NK, Granfcld JP, Jangers P. Factor influencing progresssion of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995:0(6): 1634-42.
10. Hateboer, N, v Dijk, MA, Bogdanova, N, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 1999; 353:103¬] I I ick-lirosnahan, GM. Bel/. MM. McFann, KK, et al. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study. AmJ Kidney Dis 2002: 39:1127.
12. King. BP. Torres, VE, Brummer, ME, et al. Magnetic resonance measurements of renal blood tlow as a marker of disease severiiy in autosomal-dominani polycystic kidney disease. Kidney Int 2003; 64:2214.
13- Chapman, AB, Guay-Wtxxlford, LM, Grantham, JJ, et al. Renal siruciure in early autosomal-dominant polycystic kidney disease (ADPKD): The consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int 2003; 64:1035,
14. Fick-Brosnahan, GM, Tran, ZV, Johnson. AM. et al. Progression of autosomal-dominani polycystic kidney disease in children Kidney Int 2001; 59:1654.
15. Ri/k, D, Chapman, Ali. Cystic and inherited kidney diseases. Am J Kidney Dis 2003; 12:1305.
10. The registry of nephrology, dialysis and transplantation in Turkey. Registry 200-t. The Turkish Society of Nephrology. İstanbul 2005:14.
I"7. Pırson Y, ChristopheJL, Goffîn E. Outcome of renal replacement therapy in autosomal dominant polycstic kidney disease. Nephrol Dial Transplant IWOilKSuppI 6):24-8.
18. Rose BD, Bennett WM. Corse and treatment of polycystic kidney disease. Rose BD (edst. trptodate 13.2 (www.uptoda-te.cOm), Uptodate Inc. 2005,
l(>. 1 ladimeri. H, Johansson, AC. liaraldsson, B, Nyberg, G. CAPD in patients with autosomal dominant polycystic kidney disease. Peril Dial Inl 199*. IS:)29.
20. Zeier, M, Jones. E. Ritz, E. Autosomal dominant polycystic kidney disease—the patient on renal replacement therapy. Nephrol Dial Transplant 1006; It Suppl 6:18.
21. Singh S.. Hariharan S. Renal replacement therapy in autosomal dominant polycystic kidney disease. Nephron 1991; 57:40-4.
22. Hadimeri H, Hadimeri I !, Attman PO, Nyl>erg G. Dimensions of Arteriovenous Fistulas in Patients with Autosomal Dominant Polycystic Kidney Disease. Nephron. 2000 May; K5(l):50-3.
23. Itardaji A. Martine/ Vea A. Valero A, Gutierrez C, Garcia C, Ridao C, Oliver JA, Richarl C. Cardiac involvement in auto-somal-dominant polycystic kidney disease: a hypertensive heart disease. Clin Nephrol 2001 Sep;56(3):211-20.
24. Massry and Glassock Textbook of Nephrology, 46:901.
25. Ablxitt. KC. Agodoa. LY. Polycystic kidney disease at end-stage renal disease in the United States: Patient characteristics and survival. Clin Nephrol 2002; 57:208.
26. De Y, Scalamogna A, Scanziani R, Castelnovo C, Dozio B. Rovcre G. Polycystic kidney disease and late peritoneal leakage
in CAPD: are they related^ Peril Dial Int 2002; 22:82-4.
27. Vecchei AF. Scalamogna A, Scanziani R. Castelnovo C, l>ozio B. Rovere G. Polycystic kidney disease and late peritoneal leakage in CAPD: Are they related? Perit Dial Int 2002 Jan; 22: 82-6.
28. Grantham JJ. The Jeremiah Mctzger Lecture. Polycystic kidney disease:old disease in a new context. Trans Am Clin Climatol Assoc 2002;113: 211-24.
29. Martinez-Vca A, Bardaji A, Gutierrez C, Garcia C, Peralta C, Aguilera J, Sanchez P, Vidiella J, Angelel P, Compte T, Richart C, Oliver JA. Echocardiography evaluation in patients with autosomal dominant polycy-stic kidney disease and end-stage renal disease. AmJ Kidney Dis.1999 Aug; 34(21:264-72.
30. SchefFRT, ZuckermanG, HarterH, DelmezJ, KoehlerR. Diverticular disease in patients with chronic renal failure due to polcycystic kidney disease. Ann Intern Med 1980; 92:202-4.
31. 0"Sullivan DA. Torres VE. Autosomal dominant polycystic kidney disease. Johnson RJ, Feehally J, Comprehensive Clinical Nephrology. Second Edition. Elsevier Limited 2003: 597-610.
32. Ducloux D. Motte G, Vautrin P, et al. Polycystic kidney disease as a risk factor for post-transplani dialx-tcs mcllitus Nephrol Dial Transplant 1999; 14(5): 1244-1246.
33. de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int. 2005 Feb;67(2>:714-20.
34. Hadimeri, H, Norden, G, Friman, S, Nyherg, G. Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transplant 1997; 12:1431.
35. Andreoni, KA, Pelletier, RP, Elkhammas, EA, et al. Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney disease. Transplantation 1999; 67:262.
36. Wijdicks, EF, Torres, VE, Schievink, Wl, Sterioff, S. Cerebral hemorrhage in recipients of renal transplantation. Mayo Clin Proc 1999; 74:1111.
37. Stiasny, B, Ziebell. D, Graf, S, et al. Clinical aspects of renal transplantation in polycystic kidney disease. Clin Nephrol 2002;58:16-24.
38. Shiroyanagi Y, Tanabe K, Hashimoto Y. Okuda H. Oshima T. Tokumoto T. tshikawa N, and Tomq H. Kidney transplantation in the recipient with autosomal-dominant polycystic kidney disease: a single center experience. Transplant Proceedings 2000;32:1841-3.
39. Errasti P, Manrique J. Lavilla J. Rossich E. Hernandez. A, Pujante D. Ndarabu A, Garcia N, Purroy A.Autosomal-dominant polycystic kidney disease: high prevalence of graft loss for death-re I a ted malignancies and cardiovascular risk factors. Transplant Proceedings 2003;35:1717-9.
40. Howard RJ, Reed Al, Van der Werf WJ, Silkensen JA, Patlon PR, Scornik JC. Development of polycystic disea.se in a kidney 10 years after transplantation. Transplantationl999; 68:1620.
41. Spees EK, Orlowski JP, Schorr WJ, Temple DM, Fink DW, Bruno AJ. Successful use of polycystic cadaver donor kid-neys.Spees EK et al. Transplant Proc 1990;22:374-5.
42. Siegal B. The polycystic kidney donor. Transplantation 1992; 54:1131¬43. Johnson A. Gabov P. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease . J Am Soc Nephrol. 1997; 8: 1560-7.
44.
Küçü
k M. Istanbul Tıp Fakültesi Nefroloji Bilim Dalı Transplantasyon polikliniğince izlenen hastaların demografik analizi ve greft sağkahmına etki eden faktörlerin değerlendirilmesi. Yan dal uzmanlık tezi, İstanbul. 2003.

Thank you for copying data from http://www.arastirmax.com